SlideShare a Scribd company logo
Common Transfusion
Reactions
Randal B. Covin, M.D.
Transfusion Medicine Symposium
August 6, 2016
Disclosures
• I have no financial relationships
related to this presentation.
• I will not be speaking about any
specific commercial product,
device, or medication.
• I will not be speaking of any off
label use of medications or
devices
Objectives
• State the transfusion
complication that is
prevented by transfusing
irradiated blood
components
• State the common root
cause of ABO hemolytic
transfusion reactions and
list 2 ways to prevent this
What will be covered?
Covered
• Acute
– AHTR
– FNHTR
– TRALI
– TACO
– Bacterial sepsis
• Delayed
– DHTR
Not Covered
• Acute
– Allergic
– Anaphylactic reactions
• Delayed
– Alloimmunization
– TA-GVHD
– Iron overload
– PTP
Case #1
• John R. Smith is a 71 year-old male admitted to
the cardiology unit for unstable angina
• PMH
– Coronary artery disease
» 2 vessel disease (LAD, RCA)
» s/p stents to both vessels
– Type II DM
» oral hypoglycemics
– Hypertension
– Hypercholesterolemia
Case #1
• Laboratory Results
– Hgb = 8.5 g/dL (14.0-18.0 g/dL)
– Hct = 26% (42-52%)
– PT = 12.5 sec (11-14.5 sec)
– aPTT = 31.0 sec (24-36 sec)
• 2 units of RBC ordered
• Pretransfusion Evaluation
– patient’s blood type: A-positive
– patient’s antibody screen: negative
Case #1
• Shortly after the 1st unit of RBC was started
– left lower back and abdominal pain
– temperature increased from 37.2°C to 39.8°C
– BP decreased from 130/75 mm Hg to 75/50 mm Hg
– urine – dark red
• Transfusion was stopped
• A new sample was sent to the blood bank
Blood Bank Evaluation
Pre-transfusion Post-transfusion
Clerical check OK OK
Plasma yellow red
DAT negative positive (C3d)
Antibody screen negative negative
Crossmatch compatible incompatible
Unit blood type A-positive A-positive
Patient blood type A-positive O-positive
Transfusion Reaction
Acute Hemolytic Transfusion Reaction
(AHTR)
Case #2
• 38 year-old female s/p hysterectomy for severe
abdominal pain and irregular vaginal bleeding
due to uterine fibroids unresponsive to other
therapy.
• PMH
– 2 prior pregnancies
– hypertension – well controlled
• Post-op day #2 she develops vaginal bleeding
Case #2
• Laboratory Results
– Hgb = 6.4 g/dL (12.0-16.0 g/dL)
– Hct = 19% (37-47%)
– PT = 12.6 sec (11-14.5 sec)
– aPTT = 28.2 sec (24-36 sec)
• 2 units of RBC ordered
• Pretransfusion Evaluation
– patient’s blood type: O-negative
– patient’s antibody screen: positive (anti-E)
Case #2
• Transfusion was uneventful
• Five days following the transfusion:
– temperature increased from 37.2°C to 38.2°C
– hemoglobin decreased from 8.9 g/dL to 7.1 g/dL
– urine – dark brown
– no other signs or symptoms
• A new sample was sent to the blood bank
Blood Bank Evaluation
Previous Evaluation Current Evaluation
Clerical check n/a n/a
Plasma yellow brown
DAT negative positive (IgG)
Antibody screen anti-E anti-E, anti-Jka
Unit blood type O-negative O-negative
Patient blood type O-negative O-negative
Transfusion Reaction
Delayed Hemolytic Transfusion Reaction
(DHTR)
faculty.ccbcmd.edu
Hemolytic Transfusion Reactions
• Categorization
– Acute: occurs within 24 hours of transfusion
– Delayed: occurs after 24 hours of transfusion
• Immunologic incompatibility between blood
donor and recipient
– red cells
– FFP
– platelets
www.interactive-biology.com
Acute Hemolytic Transfusion Reaction
• Incidence
–  1 : 76,000
– top 3 cause of transfusion-related death
– fatal  1 : 1.8 million
• Etiology - red cell incompatibility
– ABO
– other RBC antigens (e.g. Kell, Duffy, Kidd)
Top 10 Causes of AHTR
1) Clerical Error
2) Clerical Error
3) Clerical Error
4) Clerical Error
5) Clerical Error
6) Clerical Error
7) Clerical Error
8) Clerical Error
9) Clerical Error
10) Clerical Error
Errors
Linden, et al Transfusion 2000; 40:1207-1213
Intravascular vs Extravascular Hemolysis
Intravascular Hemolysis
• Clinical
– hemoglobinemia/-uria
– fever / chills
– hypotension
– tachycardia
– dyspnea
– nausea/vomiting
– pain
– jaundice
– complications if severe
• Laboratory
– hemoglobinemia/-uria
– ↑ ↑ Bilirubin
– ↑ ↑ LDH
– +DAT – C3d
Extravascular Hemolysis
• Clinical
– fever/chills
– jaundice
– clinically stable
– complications very rare
• Laboratory
– hemoglobinemia/-uria – rare
– ↑ Bilirubin
– ↑ LDH
– +DAT - IgG
Differential Diagnosis
• Non-immune hemolysis
– thermal injury
– hypotonic solutions
– mechanical injury
– outdated blood
• Autoimmune hemolysis
• Bacterial contamination
• FNHTR
• TRALI
• Anaphylactic reactions
Laboratory Evaluation
• clerical check
• visual inspection of serum / plasma
• DAT
• repeat ABO (pre- and post-)
• as indicated:
– repeat antibody screen (pre- and post-)
– repeat antibody identification (pre- and post-)
– repeat crossmatch (pre- and post-)
– bilirubin, LDH, haptoglobin, urinalysis, etc.
researchdx.com
Treatment
• Stop the transfusion
• Supportive treatment for the patient
– Blood pressure support
– maintain urine output (> 1 mL/kg/hr)
– pain relief
• Report the reaction to the Blood Bank
• Blood for future transfusion
Prevention
• Event reporting system
• Proper patient identification
– when samples are drawn
– when blood transfused
• Proper labeling of samples at the bedside
• Special wristbands / electronic identification systems
• Two determinations of a patient’s blood type
• Proper laboratory technique and documentation
– meticulous attention to detail
– good judgment and critical thinking
Aftermath
• Wrong patient was drawn
– roommate was drawn instead of the patient
– patient was not properly identified prior to phlebotomy
• Patient died from complications following the
transfusion reaction.
Questions for Discussion
• What if the DAT had been negative on the post-
transfusion sample:
– Would that rule-out an AHTR?
– Why could the DAT be negative after an AHTR?
• Is it OK to allow the patient’s doctor to correct a
mislabeled blood bank specimen if they can
positively identify the tube and the patient?
AABB Technical Manual
“When a sample is received in the laboratory, a
trained member of the staff must confirm that the
information on the label and on the transfusion
request is identical. If there is any doubt about
the identity of the patient, a new sample must be
obtained. It is unacceptable for anyone to
correct identifying information on an
incorrectly labeled sample.”
Technical Manual, 15th edition. AABB Press, 2005
Delayed Hemolytic Transfusion
Reaction
• Incidence  1:5000 – 1:11,000
• Etiology
– anamnestic immune response to RBC antigen
– rapid production of new antibody (very rare)
– usually extravascular hemolysis
• Hemolytic vs serologic
• Most commonly involved antibody:
– anti-Jka
Timing of DHTR
0
20
40
60
80
100
120
140
1-7 8-14 15-21 22-28 29-35 36-42 43-49 >49
Days after Transfusion
NumberofCases
• Most occur within the first 2 weeks after transfusion
Davenport RD in Popovsky MA, ed. Transfusion Reactions, 4th ed; 2012
Clinical Presentation and Diagnosis
• Clinical Presentation
– fever
– decreasing hemoglobin
– jaundice
– new positive antibody screening test
• Laboratory Evaluation
– DAT
– antibody screen and identification
– tests for hemolysis
researchdx.com
Treatment and Prevention
• Treatment
– supportive care
– identify antibody
– transfuse compatible cells as needed
• Prevention
– prevention as for AHTR
– previous records
– honor all previously identified antibodies
– not always preventable
Case #3
• 62 year-old male with GI bleeding
• PMH
– Cirrhosis
» alcohol abuse
» esophageal varices
» coagulopathy
– COPD
» mild
» tobacco use
Case #3
• Laboratory Results
– Hgb = 6.5 g/dL (14.0-18.0 g/dL)
– Hct = 20% (42-52%)
– PT = 20.6 sec (11-14.5 sec)
– aPTT = 39.2 sec (24-36 sec)
• 2 units of RBC and 2 units of FFP are ordered
for transfusion
• Pretransfusion Evaluation
– patient’s blood type = A-positive
– patient’s antibody screen = negative
Case #3
• During 2nd unit of RBC
– temperature increased from 36.8°C to 38.5°C
– mild chills
– urine – clear yellow
– no other signs or symptoms
• Transfusion was stopped
• A new sample sent to the blood bank
Blood Bank Evaluation
Pre-transfusion Post-transfusion
Clerical check OK OK
Plasma yellow yellow
DAT negative negative
Antibody screen negative negative
Crossmatch compatible compatible
Unit blood type A-positive A-positive
Patient blood type A-positive A-positive
Transfusion Reaction
Febrile, Nonhemolytic Transfusion
Reaction (FNHTR)
Incidence
• 0.1-1% of blood transfusions
• Multiple transfusions or pregnancies -  risk
• Varies by component
– platelets  4.6%
– red cells  0.33%
– FFP – rare
Clinical Presentation
• Fever
– rise in temperature of ≥ 1ºC (2ºF)
– not explained by the patient’s clinical condition
– may be absent
• Chills / rigors / cold / discomfort
• Headache
• Nausea / vomiting
• Timing
– typically occur towards the end of the transfusion
– 5-10% occur 1-2 hours after the transfusion
Etiology
• Alloimmunization – WBC or platelets
– Antibodies in patient react with donor WBC or platelets
– Donor antibodies react with patient WBC or platelets
• Storage-related cytokines
– WBC-derived: IL-1β, IL6, IL8, TNFα, etc.
– Platelet-derived: CD154, CCL5, PF4, MIP1α, TGF-β1, etc.
www.sinobiological.com
Differential Diagnosis
• Acute hemolytic transfusion reactions
• Bacterial sepsis
• TRALI
• Patient’s underlying condition
• Medications
Laboratory Evaluation
• Rule-out hemolysis
– clerical checks
– DAT
– visual check for hemolysis
– repeat typing / crossmatch
– etc.
• Rule-out bacterial sepsis
– gram stain
– culture
researchdx.com
Treatment and Prevention
• Treatment
– stop transfusion
– keep IV line open
– medication
» fever
» shaking chills
• Prevention
– leukoreduction of blood components
– premedication
– slower rate of infusion
– washing cellular components
Questions for Discussion
• What if the temperature increases by only:
– 1°F?
– 0°F?
• Should you send all these units out for culture?
• If the blood bank evaluation is negative can the
transfusion be restarted (does the unit have to
be discarded)?
Case #4
• 67 year-old male with GI bleed
• PMH
– h/o gastric ulcers
– h/o GI bleed x 2
– hypercholesterolemia
– coronary artery disease
» s/p angioplasty
» s/p stent placement (LAD, RCA)
Case #4
• Laboratory Results
– Hgb = 9.04 g/dL (14.0-18.0 g/dL)
– Hct = 27% (42-52%)
– Plt = 225,000/μL (130,000-400,000/ μL)
• 1 unit of RBC was ordered for transfusion
• Pretransfusion Evaluation
– patient’s blood type = O-negative
– patient’s antibody screen = negative
Case #4
• 45 minutes after the completion of the
transfusion the patient developed:
– severe shortness of breath (dyspnea)
– severe decrease in blood oxygen level (hypoxemia)
– low blood pressure (hypotension)
– temperature increased from 37.1°C to 38.5°C
• Chest x-ray – severe bilateral pulmonary edema
• A new sample was sent to the blood bank
Case #4
Amber Henry, MD, Darrell Triulzi, MD, and Mark Yazer, MD.
http://path.upmc.edu/cases/case509.html. May, 2007
Pre-transfusion Post-transfusion
Blood Bank Evaluation
Pre-transfusion Post-transfusion
Clerical check OK OK
Plasma yellow yellow
DAT negative negative
Antibody screen negative negative
Crossmatch compatible compatible
Unit blood type O-negative O-negative
Patient blood type O-negative O-negative
Clinical Evidence of Volume Overload (per patient’s MD): none
Transfusion Reaction
Transfusion-Related Acute Lung Injury
(TRALI)
www.immucor.com
TRALI
•
• Incidence
– 1 : 1200–1 : 190,000 components transfused
Graph: Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual
Summary for Fiscal Year 2014. www.fda.gov
Clinical Presentation
• Symptoms
– dyspnea
• CXR
– diffuse, bilateral
alveolar and interstitial
infiltrates
– no evidence of cardiac
failure
– no other cause for
pulmonary failure
• Signs
– tachypnea
– hypoxemia
– cyanosis
– fever ≥ 1°C
– hypotension
– rales
Occurring within 6 hours
of transfusion
Two-Hit Model
• First Hit
– Clinical status of the patient
» hematologic malignancy
» recent surgery (especially CPB)
» active infection or sepsis
» massive transfusion
» kidney and/or liver disease
Two-Hit Model
• Second Hit
– Transfusion of an activator
» antibody
» non-antibody
 bioactive lipids
 cytokines / cytokine receptors
 other
Activators
• Antibody-related (75-95%)
– donor antibodies (94%)
» HLA (90%)
» neutrophil (10%)
– recipient antibodies (6%)
• Non-antibody-related (5-25%)
– bioactive lipids
– cytokines/cytokine receptors
– immunoglobulins
Differential Diagnosis
• Acute lung injury / ARDS
• Transfusion-associated circulatory overload
• Severe allergic / anaphylactic reaction
• Dyspnea of unknown etiology
• Acute hemolytic transfusion reaction
Diagnosis
• Rule-out hemolysis, if necessary
• Evaluation
– volume status
– oxygenation status
– CXR
– BNP
– HLA-typing*
– HLA antibody screen and specificity*
– Neutrophil antibody screen and specificity*
– WBC crossmatch*
* patient and donor
Treatment
• Discontinue transfusion
• Supportive therapy
– supplemental O2
– intubation and mechanical ventilation
– intravenous fluids
– inotropes and vasopressors
• Additional therapy
– corticosteroids
– diuretics
Prognosis
• Complete resolution
– ≤ 4 days in 80%
– > 4 days in 20%
• Mortality = 6-14%
Implicated Components
• All blood components have been implicated
• All types of anticoagulant / preservative solutions
have been implicated
• Leukoreduced units have been implicated
• IVIg
Prevention
• High plasma volume products from:
– Males
– Females with no history of pregnancy
– Females with a history of pregnancy who have been
tested and found negative for HLA antibodies
• Pooled solvent/detergent-treated (SD) plasma
• Platelets in platelet additive solutions
Plasma-Containing Components
• High plasma-volume components
– FFP
– plasma frozen within 24 hours after phlebotomy
– cryoprecipitate-reduced plasma
– apheresis platelets
– buffy-coat-derived platelets
– whole blood
• Lower plasma-volume components
– red blood cells
– platelets prepared from whole blood
– cryoprecipitate
Case #5
• 71 year-old male admitted with left lower lobe
pneumonia
• PMH
– Coronary artery disease
» s/p CABG x 3 – 5 years ago
» h/o CHF
– COPD
» moderate
» quit smoking – 15 years ago
– Type II Diabetes Mellitus – oral hypoglycemic
Case #5
• Laboratory Results
– Hgb = 7.2 g/dL (14.0-18.0 g/dL)
– Hct = 22% (42-52%)
• 3 units of RBC are ordered for transfusion
• Pretransfusion Evaluation
– patient’s blood type = A-positive
– patient’s antibody screen = negative
Case #5
• 15 minutes after transfusion of the 3rd unit of
RBC the patient developed shortness of breath
– decreased blood oxygen level
– blood pressure increased slightly
– developed a cough productive of white sputum
Case #5
• Further patient evaluation:
– I/O = 2250 / 575 cc
• Treatment:
– furosemide 60 mg IV
• Response to treatment:
– patient responded with 1250 cc of urine output
– shortness of breath improved significantly
Case #5
http://www.meddean.luc.edu/lumen/MedEd/medicine/pulmonar/cxr/
atlas/cxratlas_f.htm
Post-transfusion Post-treatment
Transfusion Reaction
Transfusion Associated Circulatory
Overload (TACO)
Presentation
• Incidence < 1%
• Etiology volume overload
• Clinical Presentation
– shortness of breath (dyspnea)
– shortness of breath when lying flat (orthopnea)
– cough
– increased heart rate (tachycardia)
– hypertension
– headache
Risk Factors
• Small size
• Elderly
• Preexisting heart disease
• Renal failure
• Obstetrical patients
• Chronic anemia 100fstreet.com
Diagnosis/Treatment/Prevention
• Diagnosis
– chest x-ray
– intravascular volume assessment
• Treatment / Prevention
– oxygen
– upright posture
– diuretics
– fluid restriction
– prevention
» Identifying patients at risk
» avoidance of unnecessary transfusions
» diuretics
» slow rate of infusion / split unit
Case #6
• John D. Smyth is a 67 year-old male admitted
for acute myelogenous leukemia.
• PMH
– Acute myelogenous leukemia
» s/p induction induction chemotherapy
» pancytopenic
– Hypertension
– Hypercholesterolemia
Case #6
• Laboratory Results
– Hgb = 7.1 g/dL (14.0-18.0 g/dL)
– Hct = 22% (42-52%)
– Plt = 9/μL (130,000-400,000/μL)
• 1 unit of platelets ordered
• Pretransfusion Evaluation
– patient’s blood type: A-positive
– patient’s antibody screen: negative
Case #6
• Shortly after the transfusion was started
– temperature increased from 37.2°C to 40.1°C
– rigors developed
– patient became hypotensive (BP = 70/42 mmHg)
• Transfusion was stopped
• A new sample was sent to the blood bank
Blood Bank Evaluation
Pre-transfusion Post-transfusion
Clerical check OK OK
Plasma yellow yellow
DAT negative negative
Antibody screen negative negative
Crossmatch N/A N/A
Unit blood type A-positive A-positive
Patient blood type A-positive A-positive
Gram stain platelet unit = gram-negative rods
Transfusion Reaction
Bacterial Sepsis
Bacterial Contamination
• 1:3000 cellular blood components
• Risk varies among blood components
– platelets
– red blood cells
– frozen components (FFP, cryo)
• Where do the bacteria come from?
– skin overlying the venipuncture site
– unsuspected bacteremia
Increasing
Risk
Bacterial Infection
• Most common transfusion-transmitted infection
• Platelet transfusion
– Sepsis – 1:107,000
– Fatality – 1:1 million
• Red cell transfusion
– Sepsis – 1:500,000
– Fatality – 1:10 million
Microbiology
• Platelets
– skin flora
– gram-positive organisms
» Coagulase-negative staphylococci, Propionibacterium acnes
» Staphylococcus aureus, Corynebacterium, Streptococci
– gram-negative organisms
• Red Cells
– gram-negative organisms
» Yersinia enterocolitica
» Serratia liquifaciens
» Pseudomonas fluorescens
– gram-positive organisms
– autologous units affected as well (? increased risk)
Clinical Presentation
• Variable
• Fever
• Chills/rigors
• Hypotension
• Diaphoresis
• Complications
– renal failure
– ARDS
– multiorgan failure
– disseminated intravascular coagulation (DIC)
lifespa.com
Diagnosis
• Differential Diagnosis
– hemolytic transfusion reaction
– FNHTR
– TRALI
– underlying disease
• Blood Bank Evaluation
– rule-out hemolysis
– gram stain and culture of unit in question
– blood cultures from the patient
Prevention
• Appropriate transfusion of blood components
• All components
– blood donor screening
– skin disinfection prior to venipuncture
– diversion of the first 30-50 cc of blood from collection
• Platelet-specific
– single-donor (apheresis) platelets
– reducing storage duration
– bacterial detection
» culture-based
» rapid immunoasay
– pathogen inactivation
Component Modifications
Modification Decreases risk of or prevention of….
Leukoreduction CMV infection
FNHTR
alloimmunization
reperfusion injury in CABG
Irradiation TA-GVHD
Washing anaphylcatic reactions
recurrent allergic reactions
recurrent FNHTR
Who should get irradiated blood?
• Clearly at risk:
– BMT (allo and auto)
– Congenital immune deficiency
syndromes
– Intrauterine transfusions
– Neonatal exchange
transfusions
– Hodgkin’s disease
– Directed donations from blood
relatives
– HLA-matched transfusions
– Granulocyte transfusions
– Patients treated with purine
analogue drugs (e.g.
fludarabine)
• Possibly at risk:
– Acute leukemia
– Non-Hodgkin’s lymphoma
– Low birthweight infants
– Extensive chemotherapy/XRT
for solid tumors
– Solid organ transplants
– ECMO
• Not at risk:
– HIV / AIDS
Objectives
• State the transfusion
complication that is
prevented by transfusing
irradiated blood components
• State the common root
cause of ABO hemolytic
transfusion reactions and list
2 ways to prevent this
TA-GVHD
Clerical error
- proper patient identification
- proper labeling of samples at the bedside
- special wristbands / electronic identification systems
- requiring second sample for determining blood type
Any questions?
Any answers?
Any rags, any bones,
any bottles today?
- Professor Quincy Adams Wagstaff,
President, Huxley College, 1932.
Perelman SJ, Kalmar B, Ruby H, Johnstone WB. The Four Marx
Brothers - Horse Feathers. Paramount Pictures (1932)

More Related Content

What's hot

Blood components and its uses
Blood components and its usesBlood components and its uses
Blood components and its uses
Anish Gupta
 
Blood components and adverse transfusion reactions
Blood components and adverse transfusion reactionsBlood components and adverse transfusion reactions
Blood components and adverse transfusion reactions
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Blood transfusion reaction
Blood transfusion reactionBlood transfusion reaction
Blood transfusion reaction
Atifa Ambreen
 
Massive transfusion
Massive transfusionMassive transfusion
Massive transfusionRafiq Ahmad
 
Guidelines of blood transfusion
Guidelines of blood transfusionGuidelines of blood transfusion
Guidelines of blood transfusion
Dr. Mohamed Maged Kharabish
 
Red cell and platelet storage lesions and their effect in transfusion practise
Red cell and platelet storage lesions and their effect in transfusion practiseRed cell and platelet storage lesions and their effect in transfusion practise
Red cell and platelet storage lesions and their effect in transfusion practise
Arjuna Samaranayaka
 
Blood components
Blood componentsBlood components
Blood components
Dhileeban Maharajan
 
AUTOLOGOUS BLOOD TRANSFUSION
AUTOLOGOUS BLOOD TRANSFUSIONAUTOLOGOUS BLOOD TRANSFUSION
AUTOLOGOUS BLOOD TRANSFUSION
Manan Shah
 
Blood components preparation and therapeutic uses final
Blood components preparation and therapeutic uses finalBlood components preparation and therapeutic uses final
Blood components preparation and therapeutic uses finalglobalsoin
 
FEBRILE NON HEMOLYTIC TRANSFUSION REACTION
FEBRILE NON HEMOLYTIC TRANSFUSION REACTIONFEBRILE NON HEMOLYTIC TRANSFUSION REACTION
FEBRILE NON HEMOLYTIC TRANSFUSION REACTION
akshaya tomar
 
Blood Transfusion Reactions
Blood Transfusion ReactionsBlood Transfusion Reactions
Blood Transfusion Reactions
ManjuNath912460
 
Clinical Applications Of Therapeutic Apheresis
Clinical Applications Of Therapeutic ApheresisClinical Applications Of Therapeutic Apheresis
Clinical Applications Of Therapeutic ApheresisRHMBONCO
 
Therapeutic plasma exchange
Therapeutic plasma exchangeTherapeutic plasma exchange
Therapeutic plasma exchange
tareq chowdhury
 
Blood component preparation
Blood component preparationBlood component preparation
Blood component preparation
SUNIL KUMAR PEDDANA
 
Hemolytic transfusion reaction
Hemolytic transfusion reactionHemolytic transfusion reaction
Hemolytic transfusion reaction
Shreyas Kate
 
seminar on Blood transfusion
 seminar on Blood transfusion  seminar on Blood transfusion
seminar on Blood transfusion
Biswajit Deka
 
Blood transfusion & Blood Component Therapy-An Update
Blood transfusion & Blood Component Therapy-An UpdateBlood transfusion & Blood Component Therapy-An Update
Blood transfusion & Blood Component Therapy-An Update
Dr. Annasaheb Dhumale
 
BLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.ppt
BLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.pptBLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.ppt
BLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.ppt
Biniam24
 

What's hot (20)

Blood components and its uses
Blood components and its usesBlood components and its uses
Blood components and its uses
 
Blood components and adverse transfusion reactions
Blood components and adverse transfusion reactionsBlood components and adverse transfusion reactions
Blood components and adverse transfusion reactions
 
Blood transfusion reaction
Blood transfusion reactionBlood transfusion reaction
Blood transfusion reaction
 
Massive transfusion
Massive transfusionMassive transfusion
Massive transfusion
 
Guidelines of blood transfusion
Guidelines of blood transfusionGuidelines of blood transfusion
Guidelines of blood transfusion
 
Red cell and platelet storage lesions and their effect in transfusion practise
Red cell and platelet storage lesions and their effect in transfusion practiseRed cell and platelet storage lesions and their effect in transfusion practise
Red cell and platelet storage lesions and their effect in transfusion practise
 
Blood components
Blood componentsBlood components
Blood components
 
Adverse Effects Of Blood Transfusion
Adverse Effects Of Blood TransfusionAdverse Effects Of Blood Transfusion
Adverse Effects Of Blood Transfusion
 
AUTOLOGOUS BLOOD TRANSFUSION
AUTOLOGOUS BLOOD TRANSFUSIONAUTOLOGOUS BLOOD TRANSFUSION
AUTOLOGOUS BLOOD TRANSFUSION
 
Autologous Blood Transfusion
Autologous Blood TransfusionAutologous Blood Transfusion
Autologous Blood Transfusion
 
Blood components preparation and therapeutic uses final
Blood components preparation and therapeutic uses finalBlood components preparation and therapeutic uses final
Blood components preparation and therapeutic uses final
 
FEBRILE NON HEMOLYTIC TRANSFUSION REACTION
FEBRILE NON HEMOLYTIC TRANSFUSION REACTIONFEBRILE NON HEMOLYTIC TRANSFUSION REACTION
FEBRILE NON HEMOLYTIC TRANSFUSION REACTION
 
Blood Transfusion Reactions
Blood Transfusion ReactionsBlood Transfusion Reactions
Blood Transfusion Reactions
 
Clinical Applications Of Therapeutic Apheresis
Clinical Applications Of Therapeutic ApheresisClinical Applications Of Therapeutic Apheresis
Clinical Applications Of Therapeutic Apheresis
 
Therapeutic plasma exchange
Therapeutic plasma exchangeTherapeutic plasma exchange
Therapeutic plasma exchange
 
Blood component preparation
Blood component preparationBlood component preparation
Blood component preparation
 
Hemolytic transfusion reaction
Hemolytic transfusion reactionHemolytic transfusion reaction
Hemolytic transfusion reaction
 
seminar on Blood transfusion
 seminar on Blood transfusion  seminar on Blood transfusion
seminar on Blood transfusion
 
Blood transfusion & Blood Component Therapy-An Update
Blood transfusion & Blood Component Therapy-An UpdateBlood transfusion & Blood Component Therapy-An Update
Blood transfusion & Blood Component Therapy-An Update
 
BLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.ppt
BLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.pptBLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.ppt
BLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.ppt
 

Viewers also liked

Blood transfusion reactions and complications
Blood transfusion reactions and complicationsBlood transfusion reactions and complications
Blood transfusion reactions and complications
SCGH ED CME
 
Complications of blood transfusion
Complications of blood transfusionComplications of blood transfusion
Complications of blood transfusionraj kumar
 
COMPLICATIONS OF BLOOD TRANSFUSION BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR...
COMPLICATIONS OF BLOOD TRANSFUSION BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR...COMPLICATIONS OF BLOOD TRANSFUSION BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR...
COMPLICATIONS OF BLOOD TRANSFUSION BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR...
Prof Dr Bashir Ahmed Dar
 
Download Blood Transfusion Complications PowerPoint Template
Download Blood Transfusion Complications PowerPoint Template Download Blood Transfusion Complications PowerPoint Template
Download Blood Transfusion Complications PowerPoint Template
Templateforpowerpoint
 
Blood storage
Blood storageBlood storage
Blood storage
JenBash
 
Platelet transfusion 2013
Platelet transfusion 2013Platelet transfusion 2013
Platelet transfusion 2013derosaMSKCC
 
Complication of transfusion
Complication of transfusionComplication of transfusion
Complication of transfusion
Mulugeta Gobezie
 
Best Practices in Neonatal Transfusions
Best Practices in Neonatal TransfusionsBest Practices in Neonatal Transfusions
Best Practices in Neonatal TransfusionsIndepMedAssoc
 
Blood Components 101
Blood Components 101Blood Components 101
Blood Components 101
bloodbankhawaii
 
blood transfusion in neonates (British society of hematology)
blood transfusion in neonates (British society of hematology)blood transfusion in neonates (British society of hematology)
blood transfusion in neonates (British society of hematology)Souhila Bait
 
Guideline for blood transfusion in newborn (NNF)
Guideline for blood transfusion in newborn (NNF)Guideline for blood transfusion in newborn (NNF)
Guideline for blood transfusion in newborn (NNF)
mandar haval
 
COMPLICATIONS OF BLOOD TRANSFUSION
COMPLICATIONS OF BLOOD TRANSFUSIONCOMPLICATIONS OF BLOOD TRANSFUSION
COMPLICATIONS OF BLOOD TRANSFUSIONGSL medical college
 
Blood component therapy
Blood component therapyBlood component therapy
Blood component therapy
Manjunath Gemini
 
Platelet Transfusion Afshan
Platelet Transfusion AfshanPlatelet Transfusion Afshan
Platelet Transfusion AfshanZahoor Ahmed
 
Transfusion reactions
Transfusion reactionsTransfusion reactions
Transfusion reactionsdrnamratadass
 
Blood collection and preservation
Blood collection  and preservationBlood collection  and preservation
Blood collection and preservationglobalsoin
 
Blood & Blood Products
Blood & Blood ProductsBlood & Blood Products
Blood & Blood ProductsLaxinys
 
Blood components and preparation
Blood components and preparationBlood components and preparation
Blood components and preparation
rajkumarsrihari
 

Viewers also liked (18)

Blood transfusion reactions and complications
Blood transfusion reactions and complicationsBlood transfusion reactions and complications
Blood transfusion reactions and complications
 
Complications of blood transfusion
Complications of blood transfusionComplications of blood transfusion
Complications of blood transfusion
 
COMPLICATIONS OF BLOOD TRANSFUSION BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR...
COMPLICATIONS OF BLOOD TRANSFUSION BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR...COMPLICATIONS OF BLOOD TRANSFUSION BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR...
COMPLICATIONS OF BLOOD TRANSFUSION BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR...
 
Download Blood Transfusion Complications PowerPoint Template
Download Blood Transfusion Complications PowerPoint Template Download Blood Transfusion Complications PowerPoint Template
Download Blood Transfusion Complications PowerPoint Template
 
Blood storage
Blood storageBlood storage
Blood storage
 
Platelet transfusion 2013
Platelet transfusion 2013Platelet transfusion 2013
Platelet transfusion 2013
 
Complication of transfusion
Complication of transfusionComplication of transfusion
Complication of transfusion
 
Best Practices in Neonatal Transfusions
Best Practices in Neonatal TransfusionsBest Practices in Neonatal Transfusions
Best Practices in Neonatal Transfusions
 
Blood Components 101
Blood Components 101Blood Components 101
Blood Components 101
 
blood transfusion in neonates (British society of hematology)
blood transfusion in neonates (British society of hematology)blood transfusion in neonates (British society of hematology)
blood transfusion in neonates (British society of hematology)
 
Guideline for blood transfusion in newborn (NNF)
Guideline for blood transfusion in newborn (NNF)Guideline for blood transfusion in newborn (NNF)
Guideline for blood transfusion in newborn (NNF)
 
COMPLICATIONS OF BLOOD TRANSFUSION
COMPLICATIONS OF BLOOD TRANSFUSIONCOMPLICATIONS OF BLOOD TRANSFUSION
COMPLICATIONS OF BLOOD TRANSFUSION
 
Blood component therapy
Blood component therapyBlood component therapy
Blood component therapy
 
Platelet Transfusion Afshan
Platelet Transfusion AfshanPlatelet Transfusion Afshan
Platelet Transfusion Afshan
 
Transfusion reactions
Transfusion reactionsTransfusion reactions
Transfusion reactions
 
Blood collection and preservation
Blood collection  and preservationBlood collection  and preservation
Blood collection and preservation
 
Blood & Blood Products
Blood & Blood ProductsBlood & Blood Products
Blood & Blood Products
 
Blood components and preparation
Blood components and preparationBlood components and preparation
Blood components and preparation
 

Similar to Common Transfusion Reactions by Randal Covin, MD, FCAP

transfusion_reactions_and_their_management.ppt
transfusion_reactions_and_their_management.ppttransfusion_reactions_and_their_management.ppt
transfusion_reactions_and_their_management.ppt
PayelMukherjee33
 
Blood transfusion 1
Blood transfusion 1Blood transfusion 1
Blood transfusion 1
Chinna Chadayan
 
Blood transfusion basics
Blood transfusion basicsBlood transfusion basics
Blood transfusion basics
Ame Mehadi
 
045_2_blood_transfusion_0.ppt
045_2_blood_transfusion_0.ppt045_2_blood_transfusion_0.ppt
045_2_blood_transfusion_0.ppt
ayoubhasand1
 
bloodtransfusionandtransfusionreactions-170124162247.pdf
bloodtransfusionandtransfusionreactions-170124162247.pdfbloodtransfusionandtransfusionreactions-170124162247.pdf
bloodtransfusionandtransfusionreactions-170124162247.pdf
YousifAhmedDA
 
Blood transfusion and transfusion reactions
Blood transfusion and transfusion reactionsBlood transfusion and transfusion reactions
Blood transfusion and transfusion reactions
Mohamed Adan Ahmed (marwan)
 
Red cell transfusions in the critically ill compatible
Red cell transfusions in the critically ill compatibleRed cell transfusions in the critically ill compatible
Red cell transfusions in the critically ill compatibleBharath T
 
Transfusion Medicine
Transfusion MedicineTransfusion Medicine
Transfusion Medicine
Abdullah Ansari
 
9-3-19 10.20-10.50 Transfusion reactions - 2019.pdf
9-3-19 10.20-10.50 Transfusion reactions - 2019.pdf9-3-19 10.20-10.50 Transfusion reactions - 2019.pdf
9-3-19 10.20-10.50 Transfusion reactions - 2019.pdf
brandenburg00
 
adverse effects of transfusion.ppt
adverse effects of transfusion.pptadverse effects of transfusion.ppt
adverse effects of transfusion.ppt
ShaijiShahid2
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
IbthIbthipad
 
SHOT Cases - Hema Mistry.pdf
SHOT Cases - Hema Mistry.pdfSHOT Cases - Hema Mistry.pdf
SHOT Cases - Hema Mistry.pdf
RaviDara8
 
Hemolytic Transfusion reaction work up
Hemolytic Transfusion reaction work upHemolytic Transfusion reaction work up
Hemolytic Transfusion reaction work up
Amita Praveen
 
Heparin-Induced Thrombocytopenia (HIT) - Renal Perspective - Dr. Gawad
Heparin-Induced Thrombocytopenia (HIT) - Renal Perspective - Dr. GawadHeparin-Induced Thrombocytopenia (HIT) - Renal Perspective - Dr. Gawad
Heparin-Induced Thrombocytopenia (HIT) - Renal Perspective - Dr. Gawad
NephroTube - Dr.Gawad
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
Surendra Poudel
 
Anemia-MS3-Mandernach.ppt
Anemia-MS3-Mandernach.pptAnemia-MS3-Mandernach.ppt
Anemia-MS3-Mandernach.ppt
ssusercce0b5
 
Anemia-MS3-Mandernach.ppt54545454557747477
Anemia-MS3-Mandernach.ppt54545454557747477Anemia-MS3-Mandernach.ppt54545454557747477
Anemia-MS3-Mandernach.ppt54545454557747477
SARLSAICAMEDICALES
 
Anemia ms3-mandernach
Anemia ms3-mandernachAnemia ms3-mandernach
Anemia ms3-mandernach
jasar
 
Anemia-MS3-Mandernach.pptghjgjgyyuigguguh
Anemia-MS3-Mandernach.pptghjgjgyyuigguguhAnemia-MS3-Mandernach.pptghjgjgyyuigguguh
Anemia-MS3-Mandernach.pptghjgjgyyuigguguh
SARLSAICAMEDICALES
 

Similar to Common Transfusion Reactions by Randal Covin, MD, FCAP (20)

transfusion_reactions_and_their_management.ppt
transfusion_reactions_and_their_management.ppttransfusion_reactions_and_their_management.ppt
transfusion_reactions_and_their_management.ppt
 
Blood transfusion 1
Blood transfusion 1Blood transfusion 1
Blood transfusion 1
 
Blood transfusion basics
Blood transfusion basicsBlood transfusion basics
Blood transfusion basics
 
045_2_blood_transfusion_0.ppt
045_2_blood_transfusion_0.ppt045_2_blood_transfusion_0.ppt
045_2_blood_transfusion_0.ppt
 
bloodtransfusionandtransfusionreactions-170124162247.pdf
bloodtransfusionandtransfusionreactions-170124162247.pdfbloodtransfusionandtransfusionreactions-170124162247.pdf
bloodtransfusionandtransfusionreactions-170124162247.pdf
 
Blood transfusion and transfusion reactions
Blood transfusion and transfusion reactionsBlood transfusion and transfusion reactions
Blood transfusion and transfusion reactions
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
Red cell transfusions in the critically ill compatible
Red cell transfusions in the critically ill compatibleRed cell transfusions in the critically ill compatible
Red cell transfusions in the critically ill compatible
 
Transfusion Medicine
Transfusion MedicineTransfusion Medicine
Transfusion Medicine
 
9-3-19 10.20-10.50 Transfusion reactions - 2019.pdf
9-3-19 10.20-10.50 Transfusion reactions - 2019.pdf9-3-19 10.20-10.50 Transfusion reactions - 2019.pdf
9-3-19 10.20-10.50 Transfusion reactions - 2019.pdf
 
adverse effects of transfusion.ppt
adverse effects of transfusion.pptadverse effects of transfusion.ppt
adverse effects of transfusion.ppt
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
SHOT Cases - Hema Mistry.pdf
SHOT Cases - Hema Mistry.pdfSHOT Cases - Hema Mistry.pdf
SHOT Cases - Hema Mistry.pdf
 
Hemolytic Transfusion reaction work up
Hemolytic Transfusion reaction work upHemolytic Transfusion reaction work up
Hemolytic Transfusion reaction work up
 
Heparin-Induced Thrombocytopenia (HIT) - Renal Perspective - Dr. Gawad
Heparin-Induced Thrombocytopenia (HIT) - Renal Perspective - Dr. GawadHeparin-Induced Thrombocytopenia (HIT) - Renal Perspective - Dr. Gawad
Heparin-Induced Thrombocytopenia (HIT) - Renal Perspective - Dr. Gawad
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
Anemia-MS3-Mandernach.ppt
Anemia-MS3-Mandernach.pptAnemia-MS3-Mandernach.ppt
Anemia-MS3-Mandernach.ppt
 
Anemia-MS3-Mandernach.ppt54545454557747477
Anemia-MS3-Mandernach.ppt54545454557747477Anemia-MS3-Mandernach.ppt54545454557747477
Anemia-MS3-Mandernach.ppt54545454557747477
 
Anemia ms3-mandernach
Anemia ms3-mandernachAnemia ms3-mandernach
Anemia ms3-mandernach
 
Anemia-MS3-Mandernach.pptghjgjgyyuigguguh
Anemia-MS3-Mandernach.pptghjgjgyyuigguguhAnemia-MS3-Mandernach.pptghjgjgyyuigguguh
Anemia-MS3-Mandernach.pptghjgjgyyuigguguh
 

Recently uploaded

New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 

Recently uploaded (20)

New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 

Common Transfusion Reactions by Randal Covin, MD, FCAP

  • 1. Common Transfusion Reactions Randal B. Covin, M.D. Transfusion Medicine Symposium August 6, 2016
  • 2. Disclosures • I have no financial relationships related to this presentation. • I will not be speaking about any specific commercial product, device, or medication. • I will not be speaking of any off label use of medications or devices
  • 3. Objectives • State the transfusion complication that is prevented by transfusing irradiated blood components • State the common root cause of ABO hemolytic transfusion reactions and list 2 ways to prevent this
  • 4. What will be covered? Covered • Acute – AHTR – FNHTR – TRALI – TACO – Bacterial sepsis • Delayed – DHTR Not Covered • Acute – Allergic – Anaphylactic reactions • Delayed – Alloimmunization – TA-GVHD – Iron overload – PTP
  • 5. Case #1 • John R. Smith is a 71 year-old male admitted to the cardiology unit for unstable angina • PMH – Coronary artery disease » 2 vessel disease (LAD, RCA) » s/p stents to both vessels – Type II DM » oral hypoglycemics – Hypertension – Hypercholesterolemia
  • 6. Case #1 • Laboratory Results – Hgb = 8.5 g/dL (14.0-18.0 g/dL) – Hct = 26% (42-52%) – PT = 12.5 sec (11-14.5 sec) – aPTT = 31.0 sec (24-36 sec) • 2 units of RBC ordered • Pretransfusion Evaluation – patient’s blood type: A-positive – patient’s antibody screen: negative
  • 7. Case #1 • Shortly after the 1st unit of RBC was started – left lower back and abdominal pain – temperature increased from 37.2°C to 39.8°C – BP decreased from 130/75 mm Hg to 75/50 mm Hg – urine – dark red • Transfusion was stopped • A new sample was sent to the blood bank
  • 8. Blood Bank Evaluation Pre-transfusion Post-transfusion Clerical check OK OK Plasma yellow red DAT negative positive (C3d) Antibody screen negative negative Crossmatch compatible incompatible Unit blood type A-positive A-positive Patient blood type A-positive O-positive
  • 9. Transfusion Reaction Acute Hemolytic Transfusion Reaction (AHTR)
  • 10. Case #2 • 38 year-old female s/p hysterectomy for severe abdominal pain and irregular vaginal bleeding due to uterine fibroids unresponsive to other therapy. • PMH – 2 prior pregnancies – hypertension – well controlled • Post-op day #2 she develops vaginal bleeding
  • 11. Case #2 • Laboratory Results – Hgb = 6.4 g/dL (12.0-16.0 g/dL) – Hct = 19% (37-47%) – PT = 12.6 sec (11-14.5 sec) – aPTT = 28.2 sec (24-36 sec) • 2 units of RBC ordered • Pretransfusion Evaluation – patient’s blood type: O-negative – patient’s antibody screen: positive (anti-E)
  • 12. Case #2 • Transfusion was uneventful • Five days following the transfusion: – temperature increased from 37.2°C to 38.2°C – hemoglobin decreased from 8.9 g/dL to 7.1 g/dL – urine – dark brown – no other signs or symptoms • A new sample was sent to the blood bank
  • 13. Blood Bank Evaluation Previous Evaluation Current Evaluation Clerical check n/a n/a Plasma yellow brown DAT negative positive (IgG) Antibody screen anti-E anti-E, anti-Jka Unit blood type O-negative O-negative Patient blood type O-negative O-negative
  • 14. Transfusion Reaction Delayed Hemolytic Transfusion Reaction (DHTR) faculty.ccbcmd.edu
  • 15. Hemolytic Transfusion Reactions • Categorization – Acute: occurs within 24 hours of transfusion – Delayed: occurs after 24 hours of transfusion • Immunologic incompatibility between blood donor and recipient – red cells – FFP – platelets www.interactive-biology.com
  • 16. Acute Hemolytic Transfusion Reaction • Incidence –  1 : 76,000 – top 3 cause of transfusion-related death – fatal  1 : 1.8 million • Etiology - red cell incompatibility – ABO – other RBC antigens (e.g. Kell, Duffy, Kidd)
  • 17. Top 10 Causes of AHTR 1) Clerical Error 2) Clerical Error 3) Clerical Error 4) Clerical Error 5) Clerical Error 6) Clerical Error 7) Clerical Error 8) Clerical Error 9) Clerical Error 10) Clerical Error
  • 18. Errors Linden, et al Transfusion 2000; 40:1207-1213
  • 19. Intravascular vs Extravascular Hemolysis Intravascular Hemolysis • Clinical – hemoglobinemia/-uria – fever / chills – hypotension – tachycardia – dyspnea – nausea/vomiting – pain – jaundice – complications if severe • Laboratory – hemoglobinemia/-uria – ↑ ↑ Bilirubin – ↑ ↑ LDH – +DAT – C3d Extravascular Hemolysis • Clinical – fever/chills – jaundice – clinically stable – complications very rare • Laboratory – hemoglobinemia/-uria – rare – ↑ Bilirubin – ↑ LDH – +DAT - IgG
  • 20. Differential Diagnosis • Non-immune hemolysis – thermal injury – hypotonic solutions – mechanical injury – outdated blood • Autoimmune hemolysis • Bacterial contamination • FNHTR • TRALI • Anaphylactic reactions
  • 21. Laboratory Evaluation • clerical check • visual inspection of serum / plasma • DAT • repeat ABO (pre- and post-) • as indicated: – repeat antibody screen (pre- and post-) – repeat antibody identification (pre- and post-) – repeat crossmatch (pre- and post-) – bilirubin, LDH, haptoglobin, urinalysis, etc. researchdx.com
  • 22. Treatment • Stop the transfusion • Supportive treatment for the patient – Blood pressure support – maintain urine output (> 1 mL/kg/hr) – pain relief • Report the reaction to the Blood Bank • Blood for future transfusion
  • 23. Prevention • Event reporting system • Proper patient identification – when samples are drawn – when blood transfused • Proper labeling of samples at the bedside • Special wristbands / electronic identification systems • Two determinations of a patient’s blood type • Proper laboratory technique and documentation – meticulous attention to detail – good judgment and critical thinking
  • 24. Aftermath • Wrong patient was drawn – roommate was drawn instead of the patient – patient was not properly identified prior to phlebotomy • Patient died from complications following the transfusion reaction.
  • 25. Questions for Discussion • What if the DAT had been negative on the post- transfusion sample: – Would that rule-out an AHTR? – Why could the DAT be negative after an AHTR? • Is it OK to allow the patient’s doctor to correct a mislabeled blood bank specimen if they can positively identify the tube and the patient?
  • 26. AABB Technical Manual “When a sample is received in the laboratory, a trained member of the staff must confirm that the information on the label and on the transfusion request is identical. If there is any doubt about the identity of the patient, a new sample must be obtained. It is unacceptable for anyone to correct identifying information on an incorrectly labeled sample.” Technical Manual, 15th edition. AABB Press, 2005
  • 27. Delayed Hemolytic Transfusion Reaction • Incidence  1:5000 – 1:11,000 • Etiology – anamnestic immune response to RBC antigen – rapid production of new antibody (very rare) – usually extravascular hemolysis • Hemolytic vs serologic • Most commonly involved antibody: – anti-Jka
  • 28. Timing of DHTR 0 20 40 60 80 100 120 140 1-7 8-14 15-21 22-28 29-35 36-42 43-49 >49 Days after Transfusion NumberofCases • Most occur within the first 2 weeks after transfusion Davenport RD in Popovsky MA, ed. Transfusion Reactions, 4th ed; 2012
  • 29. Clinical Presentation and Diagnosis • Clinical Presentation – fever – decreasing hemoglobin – jaundice – new positive antibody screening test • Laboratory Evaluation – DAT – antibody screen and identification – tests for hemolysis researchdx.com
  • 30. Treatment and Prevention • Treatment – supportive care – identify antibody – transfuse compatible cells as needed • Prevention – prevention as for AHTR – previous records – honor all previously identified antibodies – not always preventable
  • 31. Case #3 • 62 year-old male with GI bleeding • PMH – Cirrhosis » alcohol abuse » esophageal varices » coagulopathy – COPD » mild » tobacco use
  • 32. Case #3 • Laboratory Results – Hgb = 6.5 g/dL (14.0-18.0 g/dL) – Hct = 20% (42-52%) – PT = 20.6 sec (11-14.5 sec) – aPTT = 39.2 sec (24-36 sec) • 2 units of RBC and 2 units of FFP are ordered for transfusion • Pretransfusion Evaluation – patient’s blood type = A-positive – patient’s antibody screen = negative
  • 33. Case #3 • During 2nd unit of RBC – temperature increased from 36.8°C to 38.5°C – mild chills – urine – clear yellow – no other signs or symptoms • Transfusion was stopped • A new sample sent to the blood bank
  • 34. Blood Bank Evaluation Pre-transfusion Post-transfusion Clerical check OK OK Plasma yellow yellow DAT negative negative Antibody screen negative negative Crossmatch compatible compatible Unit blood type A-positive A-positive Patient blood type A-positive A-positive
  • 35. Transfusion Reaction Febrile, Nonhemolytic Transfusion Reaction (FNHTR)
  • 36. Incidence • 0.1-1% of blood transfusions • Multiple transfusions or pregnancies -  risk • Varies by component – platelets  4.6% – red cells  0.33% – FFP – rare
  • 37. Clinical Presentation • Fever – rise in temperature of ≥ 1ºC (2ºF) – not explained by the patient’s clinical condition – may be absent • Chills / rigors / cold / discomfort • Headache • Nausea / vomiting • Timing – typically occur towards the end of the transfusion – 5-10% occur 1-2 hours after the transfusion
  • 38. Etiology • Alloimmunization – WBC or platelets – Antibodies in patient react with donor WBC or platelets – Donor antibodies react with patient WBC or platelets • Storage-related cytokines – WBC-derived: IL-1β, IL6, IL8, TNFα, etc. – Platelet-derived: CD154, CCL5, PF4, MIP1α, TGF-β1, etc. www.sinobiological.com
  • 39. Differential Diagnosis • Acute hemolytic transfusion reactions • Bacterial sepsis • TRALI • Patient’s underlying condition • Medications
  • 40. Laboratory Evaluation • Rule-out hemolysis – clerical checks – DAT – visual check for hemolysis – repeat typing / crossmatch – etc. • Rule-out bacterial sepsis – gram stain – culture researchdx.com
  • 41. Treatment and Prevention • Treatment – stop transfusion – keep IV line open – medication » fever » shaking chills • Prevention – leukoreduction of blood components – premedication – slower rate of infusion – washing cellular components
  • 42. Questions for Discussion • What if the temperature increases by only: – 1°F? – 0°F? • Should you send all these units out for culture? • If the blood bank evaluation is negative can the transfusion be restarted (does the unit have to be discarded)?
  • 43. Case #4 • 67 year-old male with GI bleed • PMH – h/o gastric ulcers – h/o GI bleed x 2 – hypercholesterolemia – coronary artery disease » s/p angioplasty » s/p stent placement (LAD, RCA)
  • 44. Case #4 • Laboratory Results – Hgb = 9.04 g/dL (14.0-18.0 g/dL) – Hct = 27% (42-52%) – Plt = 225,000/μL (130,000-400,000/ μL) • 1 unit of RBC was ordered for transfusion • Pretransfusion Evaluation – patient’s blood type = O-negative – patient’s antibody screen = negative
  • 45. Case #4 • 45 minutes after the completion of the transfusion the patient developed: – severe shortness of breath (dyspnea) – severe decrease in blood oxygen level (hypoxemia) – low blood pressure (hypotension) – temperature increased from 37.1°C to 38.5°C • Chest x-ray – severe bilateral pulmonary edema • A new sample was sent to the blood bank
  • 46. Case #4 Amber Henry, MD, Darrell Triulzi, MD, and Mark Yazer, MD. http://path.upmc.edu/cases/case509.html. May, 2007 Pre-transfusion Post-transfusion
  • 47. Blood Bank Evaluation Pre-transfusion Post-transfusion Clerical check OK OK Plasma yellow yellow DAT negative negative Antibody screen negative negative Crossmatch compatible compatible Unit blood type O-negative O-negative Patient blood type O-negative O-negative Clinical Evidence of Volume Overload (per patient’s MD): none
  • 48. Transfusion Reaction Transfusion-Related Acute Lung Injury (TRALI) www.immucor.com
  • 49. TRALI • • Incidence – 1 : 1200–1 : 190,000 components transfused Graph: Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2014. www.fda.gov
  • 50. Clinical Presentation • Symptoms – dyspnea • CXR – diffuse, bilateral alveolar and interstitial infiltrates – no evidence of cardiac failure – no other cause for pulmonary failure • Signs – tachypnea – hypoxemia – cyanosis – fever ≥ 1°C – hypotension – rales Occurring within 6 hours of transfusion
  • 51. Two-Hit Model • First Hit – Clinical status of the patient » hematologic malignancy » recent surgery (especially CPB) » active infection or sepsis » massive transfusion » kidney and/or liver disease
  • 52. Two-Hit Model • Second Hit – Transfusion of an activator » antibody » non-antibody  bioactive lipids  cytokines / cytokine receptors  other
  • 53. Activators • Antibody-related (75-95%) – donor antibodies (94%) » HLA (90%) » neutrophil (10%) – recipient antibodies (6%) • Non-antibody-related (5-25%) – bioactive lipids – cytokines/cytokine receptors – immunoglobulins
  • 54. Differential Diagnosis • Acute lung injury / ARDS • Transfusion-associated circulatory overload • Severe allergic / anaphylactic reaction • Dyspnea of unknown etiology • Acute hemolytic transfusion reaction
  • 55. Diagnosis • Rule-out hemolysis, if necessary • Evaluation – volume status – oxygenation status – CXR – BNP – HLA-typing* – HLA antibody screen and specificity* – Neutrophil antibody screen and specificity* – WBC crossmatch* * patient and donor
  • 56. Treatment • Discontinue transfusion • Supportive therapy – supplemental O2 – intubation and mechanical ventilation – intravenous fluids – inotropes and vasopressors • Additional therapy – corticosteroids – diuretics
  • 57. Prognosis • Complete resolution – ≤ 4 days in 80% – > 4 days in 20% • Mortality = 6-14%
  • 58. Implicated Components • All blood components have been implicated • All types of anticoagulant / preservative solutions have been implicated • Leukoreduced units have been implicated • IVIg
  • 59. Prevention • High plasma volume products from: – Males – Females with no history of pregnancy – Females with a history of pregnancy who have been tested and found negative for HLA antibodies • Pooled solvent/detergent-treated (SD) plasma • Platelets in platelet additive solutions
  • 60. Plasma-Containing Components • High plasma-volume components – FFP – plasma frozen within 24 hours after phlebotomy – cryoprecipitate-reduced plasma – apheresis platelets – buffy-coat-derived platelets – whole blood • Lower plasma-volume components – red blood cells – platelets prepared from whole blood – cryoprecipitate
  • 61. Case #5 • 71 year-old male admitted with left lower lobe pneumonia • PMH – Coronary artery disease » s/p CABG x 3 – 5 years ago » h/o CHF – COPD » moderate » quit smoking – 15 years ago – Type II Diabetes Mellitus – oral hypoglycemic
  • 62. Case #5 • Laboratory Results – Hgb = 7.2 g/dL (14.0-18.0 g/dL) – Hct = 22% (42-52%) • 3 units of RBC are ordered for transfusion • Pretransfusion Evaluation – patient’s blood type = A-positive – patient’s antibody screen = negative
  • 63. Case #5 • 15 minutes after transfusion of the 3rd unit of RBC the patient developed shortness of breath – decreased blood oxygen level – blood pressure increased slightly – developed a cough productive of white sputum
  • 64. Case #5 • Further patient evaluation: – I/O = 2250 / 575 cc • Treatment: – furosemide 60 mg IV • Response to treatment: – patient responded with 1250 cc of urine output – shortness of breath improved significantly
  • 66. Transfusion Reaction Transfusion Associated Circulatory Overload (TACO)
  • 67. Presentation • Incidence < 1% • Etiology volume overload • Clinical Presentation – shortness of breath (dyspnea) – shortness of breath when lying flat (orthopnea) – cough – increased heart rate (tachycardia) – hypertension – headache
  • 68. Risk Factors • Small size • Elderly • Preexisting heart disease • Renal failure • Obstetrical patients • Chronic anemia 100fstreet.com
  • 69. Diagnosis/Treatment/Prevention • Diagnosis – chest x-ray – intravascular volume assessment • Treatment / Prevention – oxygen – upright posture – diuretics – fluid restriction – prevention » Identifying patients at risk » avoidance of unnecessary transfusions » diuretics » slow rate of infusion / split unit
  • 70. Case #6 • John D. Smyth is a 67 year-old male admitted for acute myelogenous leukemia. • PMH – Acute myelogenous leukemia » s/p induction induction chemotherapy » pancytopenic – Hypertension – Hypercholesterolemia
  • 71. Case #6 • Laboratory Results – Hgb = 7.1 g/dL (14.0-18.0 g/dL) – Hct = 22% (42-52%) – Plt = 9/μL (130,000-400,000/μL) • 1 unit of platelets ordered • Pretransfusion Evaluation – patient’s blood type: A-positive – patient’s antibody screen: negative
  • 72. Case #6 • Shortly after the transfusion was started – temperature increased from 37.2°C to 40.1°C – rigors developed – patient became hypotensive (BP = 70/42 mmHg) • Transfusion was stopped • A new sample was sent to the blood bank
  • 73. Blood Bank Evaluation Pre-transfusion Post-transfusion Clerical check OK OK Plasma yellow yellow DAT negative negative Antibody screen negative negative Crossmatch N/A N/A Unit blood type A-positive A-positive Patient blood type A-positive A-positive Gram stain platelet unit = gram-negative rods
  • 75. Bacterial Contamination • 1:3000 cellular blood components • Risk varies among blood components – platelets – red blood cells – frozen components (FFP, cryo) • Where do the bacteria come from? – skin overlying the venipuncture site – unsuspected bacteremia Increasing Risk
  • 76. Bacterial Infection • Most common transfusion-transmitted infection • Platelet transfusion – Sepsis – 1:107,000 – Fatality – 1:1 million • Red cell transfusion – Sepsis – 1:500,000 – Fatality – 1:10 million
  • 77. Microbiology • Platelets – skin flora – gram-positive organisms » Coagulase-negative staphylococci, Propionibacterium acnes » Staphylococcus aureus, Corynebacterium, Streptococci – gram-negative organisms • Red Cells – gram-negative organisms » Yersinia enterocolitica » Serratia liquifaciens » Pseudomonas fluorescens – gram-positive organisms – autologous units affected as well (? increased risk)
  • 78. Clinical Presentation • Variable • Fever • Chills/rigors • Hypotension • Diaphoresis • Complications – renal failure – ARDS – multiorgan failure – disseminated intravascular coagulation (DIC) lifespa.com
  • 79. Diagnosis • Differential Diagnosis – hemolytic transfusion reaction – FNHTR – TRALI – underlying disease • Blood Bank Evaluation – rule-out hemolysis – gram stain and culture of unit in question – blood cultures from the patient
  • 80. Prevention • Appropriate transfusion of blood components • All components – blood donor screening – skin disinfection prior to venipuncture – diversion of the first 30-50 cc of blood from collection • Platelet-specific – single-donor (apheresis) platelets – reducing storage duration – bacterial detection » culture-based » rapid immunoasay – pathogen inactivation
  • 81. Component Modifications Modification Decreases risk of or prevention of…. Leukoreduction CMV infection FNHTR alloimmunization reperfusion injury in CABG Irradiation TA-GVHD Washing anaphylcatic reactions recurrent allergic reactions recurrent FNHTR
  • 82. Who should get irradiated blood? • Clearly at risk: – BMT (allo and auto) – Congenital immune deficiency syndromes – Intrauterine transfusions – Neonatal exchange transfusions – Hodgkin’s disease – Directed donations from blood relatives – HLA-matched transfusions – Granulocyte transfusions – Patients treated with purine analogue drugs (e.g. fludarabine) • Possibly at risk: – Acute leukemia – Non-Hodgkin’s lymphoma – Low birthweight infants – Extensive chemotherapy/XRT for solid tumors – Solid organ transplants – ECMO • Not at risk: – HIV / AIDS
  • 83. Objectives • State the transfusion complication that is prevented by transfusing irradiated blood components • State the common root cause of ABO hemolytic transfusion reactions and list 2 ways to prevent this TA-GVHD Clerical error - proper patient identification - proper labeling of samples at the bedside - special wristbands / electronic identification systems - requiring second sample for determining blood type
  • 84. Any questions? Any answers? Any rags, any bones, any bottles today? - Professor Quincy Adams Wagstaff, President, Huxley College, 1932. Perelman SJ, Kalmar B, Ruby H, Johnstone WB. The Four Marx Brothers - Horse Feathers. Paramount Pictures (1932)